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between national culture and EQ-5D value sets. Method Rank correlation analysis is 
used to explore relationships between the relative values of a set of EQ-5D states and 
dimensions of national culture. The latter are taken from Hofstede’s framework which 
operationalizes national culture in 5 dimensions. The analysis is carried out using data 
from the countries for which EQ-5D value sets and scores on Hofstede’s dimensions 
of culture both exist: Argentina, Denmark, Germany, Japan, Korea, The Netherlands, 
Poland, Spain, UK, USA. Results Some relationships among the EQ-5D dimensions 
and culture are observed. Eg. the culture dimension: Power-Distance correlates 
strongly with the EQ-5D dimension: Anxiety-Depression (Spearman’s Rho for Power-
Distance indices and TTO valuations of EQ-5D states 11112 and 11113 are 0.523 
and 0.815 respectively). Strong and moderate relationships are observed among other 
culture dimensions (Individualism, Masculinity, Uncertainty-Avoidance) and EQ-5D 
dimensions (Pain, Self-Care). Discussion Different cultures appear to value EQ-5D 
dimensions differently. The correlation patterns observed in this study are generally 
consistent with a priori expectations based on the nature of the dimensions of culture 
and the EQ-5D model. This analysis demonstrates the potential of national culture in 
providing insight into the drivers of the relative values of EQ-5D dimensions for dif-
ferent countries, and in informing decisions about which EQ-5D value sets to use in 
situations where one does not exist.
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ARE HEALTH STATES “TIMELESS”? A TEST OF THE UTILITY 
INDEPENDENCE ASSUMPTION: COMPARING A REPEATED MEASURES 
DESIGN AND LATENT GROWTH MODELING
Franic D1, Gafni A2, Vandenberg R1
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OBJECTIVES Primary study objective was to test whether individuals’ responses to 
standard gamble (SG) questions do not depend on the duration of time spent in the 
health scenario presented (“timelessness”). Secondary objective of the study was to 
test the “timelessness” of VAS responses. METHODS Face-to-face interviews were 
conducted in a convenience sample of healthy volunteers (n = 59) aged 20 to 63. 
Individuals rated their preferences for three health states of varying post chemotherapy 
nausea and vomiting (PCNV) severity and current health, assuming six different time 
horizons. Repeated measures analysis of variance (RM-ANOVA) was conducted 
(SX6X4X2) to determine the affect of time (6 levels:3 days, 3 months, 1-, 5- and 
20- year(s) and rest of life), health state (4 levels: mild, moderate and severe PCNV 
and current health), and method (2 levels: SG and VAS) on preference. RESULTS 
Results were analyzed using RM-ANOVA and latent growth modeling (LGM). Both 
showed that preferences decreased over time for SG and VAS (p < 0.05). For the 
RM-ANOVA, all main effects and interaction terms were signiﬁcant (p < 0.05). LGM 
showed acceptable ﬁt and signiﬁcant slope parameters for all PCNV. The slopes were 
decreasing over time. Signiﬁcant latent variances for LGM showed that not all indi-
viduals change at the same rate over time (p < 0.05) CONCLUSIONS There is a clear 
advantage in the use of LGM over RM-ANOVA because LGM can evaluate group 
differences in addition to individual changes over time. For the majority of respondents 
the utility independence assumption for SG and VAS did not hold both at the group 
and the individual level. Similar to Bala et al (1999) and Franic et al (2003) the results 
of this study indicated preferences as measured by SG and VAS are not timeless. 
Regardless of the preference measure used: both SG and VAS yield higher preferences 
for shorter time horizons.
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COMPARATIVE PERFORMANCE OF RISK ADJUSTMENT MEASURES IN A 
SAMPLE OF COMMERCIALLY-INSURED PATIENTS UNDER AGE 65—
TWO SIMPLE MEASURES OUTPERFORM CURRENT STANDARDS
Fowler R, Johnston SS
Thomson Reuters, Washington, DC, USA
OBJECTIVES: Numerous studies have compared risk adjustment measures (RAMs), 
yet none have done so across various outcomes in multiple acute and chronic condi-
tions in a single database with uniform programmatic operationalization. This study 
compares the performance of 7 RAMs and highlights practical programming consid-
erations for hands-on data analysts operationalizing RAMs. METHODS: Data were 
administrative claims from the 2006–2008 MarketScan® Commercial Database. 
Seven RAMs (2 Deyo-Charlson Comorbidity Index variations, Chronic Disease Score 
[CDS], 2 3-digit ICD-9-CM code count variations, number of unique National Drug 
Classiﬁcation [NDC] codes, and number of unique drug molecules) measured over a 
1-year baseline period were compared in 7 conditions (acute coronary syndrome, 
sample N = 14,951; rheumatoid arthritis [RA], N = 27,085; depression, N = 129,206; 
diabetes, N = 126,087; hypertension, N = 225,080; asthma, N = 56,172; ﬁbromyalgia, 
N = 52,365) on the basis of 3 outcomes (total health care cost, emergency room [ER] 
visits, inpatient admissions) measured over a 1-year follow-up period. Goodness-of-ﬁt 
statistics (chi-squared statistic for total health care costs and c-statistic for ER visits 
and inpatient admissions) were compared across age and sex-adjusted regression 
models for each individual RAM. RESULTS: A unique 3-digit ICD-9-CM code count 
that excluded ‘rule-out’ diagnoses consistently outperformed, i.e., had highest chi-
squared and c-statistics, every other RAM in every condition and outcome with the 
exception of the number of unique NDC codes, which performed the best for all 
outcomes in depression and ﬁbromyalgia patients. The number of unique NDC codes 
was generally the second-best performing RAM across all outcomes. The CDS per-
formed worst across every condition and outcome. CONCLUSIONS: Complex RAMs 
are subject to inconsistencies in their operationalization and application from a pro-
gramming perspective. Across multiple acute and chronic conditions, the two simplest 
and programmatically-transparent RAMs were the most predictive measures of total 
health care cost, ER visits, and inpatient admissions.
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IMPACT OF ADHERENCE WITH STATIN THERAPY ON 
HOSPITALIZATION RISK AND MORTALITY AMONG PATIENTS  
WITH DIABETES
Yang Y, Banahan BF, Pace PF
University of Mississippi, University, MS, USA
OBJECTIVES: The objective of this study was to evaluate the impact of adherence 
with statin therapy on diabetes-speciﬁc hospitalization and all-cause mortality among 
patients with diabetes enrolled in a state Medicaid program. METHODS: The authors 
conducted a retrospective cohort study of patients with diabetes who were continu-
ously enrolled in a state Medicaid program from January 2002 to December 2004. 
The date of the ﬁrst medication claim for statin during the ﬁrst six months of 2002 
was the index date. Adherence to statin was assessed within one year following the 
index date. Adherence was assessed using the proportion of days covered (PDC) and 
patients with a PDC of 0.8 or greater considered being adherent. The primary out-
comes of interest were diabetes-speciﬁc hospitalization and all-cause mortality during 
the follow-up period (end of adherence measurement to December 31, 2004). Multi-
variate regression analyses were performed to assess the impact of adherence with 
statin therapy on outcome measures. RESULTS: A total 10,839 patients were included 
in the study. Mean age 60.3 ± 10.0 years, 23.8% male, 76.2 female; 31.7% white, 
50.4% black. At 12 months after the index prescription, only 23.9% of patients were 
adherent with their prescribed statin therapy. During follow-up After controlling for 
age, gender, race, prior hospitalization, and Charlson comorbidity index, patients who 
were adherent to statin therapy were 48.7% (OR: 0.513; 95%CI: 0.421–0.624) less 
likely to have diabetes-speciﬁc hospital admissions in comparison to nonadherent 
patients. Adherence with statin therapy had no statistically signiﬁcant impact on all-
cause mortality (OR: 0.801; 95%CI: 0.454–1.412). CONCLUSIONS: Adherence 
with statin therapy was poor among patients with diabetes enrolled in a Medicaid 
program. Adherence with statin therapy was associated with signiﬁcantly less risk for 
diabetes-speciﬁc hospitalization. Greater efforts are needed to facilitate diabetes self-
management behaviors to improve patient outcomes.
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OBJECTIVES: To examine the risk of falls/fractures associated with atypical antipsy-
chotic use compared to typical antipsychotic use in community dwelling older adults. 
METHODS: The population based retrospective cohort analysis based on propensity 
score matching was conducted using IMS LifeLink™ Health Plan claims data. Patients 
were included in the cohort if they met following criteria: ≥ 50 years of age, new users 
of atypical or conventional antipsychotics who began taking antipsychotics between 
July 2000 and December 2007, and continuously enrolled for six months before and 
at least six months after initiation of antipsychotic treatment. Patients taking atypical 
antipsychotics were matched with those using typical antipsychotics using propensity 
score greedy matching technique. Kaplan-Meier survival curves and Cox proportional 
hazard model stratiﬁed on matched pair was employed to examine risk of hospitaliza-
tion/emergency visit due to falls or femur fractures within one year. Duration of 
antipsychotic therapy and exposure to other psychotropic medications were controlled 
for in the ﬁnal model. RESULTS: A total of 11,160 older adults (5,580 atypical and 
5,580 typical users) were identiﬁed as new users of antipsychotics after matching. 
Within one year of follow up period, 456 patients (8.06 %) in atypical drug group 
had falls/femur fractures compared to 375 (6.72%) in typical antipsychotic group. No 
signiﬁcant difference was found between atypical users compared to typical agents 
with respect to risk of falls/fractures [Hazard Ration (HR) 1.01, 95% CI 0.83–1.22]. 
However, duration of therapy more than 90 days was signiﬁcantly (HR, 1.81, CI, 
1.35–2.43) associated with increased risk of falls/fractures compared to less than 30 
days. CONCLUSIONS: The study results show no signiﬁcant difference in the risk of 
falls/fractures between atypical and typical antipsychotic use among older adults. 
However, there is a need to be cautious while prescribing atypical and typical anti-
psychotics in older adults for longer periods of time.
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CONFOUNDING EFFECT OF AGE IN THE ASSOCIATION OF 
CARDIOVASCULAR RISK AND DIETARY SUPPLEMENT USE  
AMONG US ADULTS
Yu S, Shaw JW, Crawford SY, Groo V
University of Illinois at Chicago, Chicago, IL, USA
OBJECTIVES: Dietary supplement (DS) use has been found to be associated with 
cardiovascular disease (CVD) risk. This study assessed whether age moderates or 
confounds the association between CVD risk and DS use. METHODS: Data were 
taken from the 1999–2004 waves of the National Health and Nutrition Examination 
Survey. Inferences were restricted to US population members ≥20 years of age as 
